# Thiotepa

NDC: 72205-045
Generic name: Thiotepa
Labeler / Manufacturer: Novadoz Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Marketing started: 20200201

FDA application: ANDA213049

## Active ingredients

- THIOTEPA: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72205-045"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72205-045
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b702dcc9-dd0e-4386-b1e2-f20562fd2ad9